Pinnacle Spine Group has announced the CE Mark (Conformité Européenne) approval for its entire line of InFill Interbody Devices, as well as its patented InFill Graft Delivery System. Pinnacle’s line of interbody devices includes the InFill Direct Lateral system, the InFill Lordotic Oblique TLIF, the InFill Convex Oblique TLIF, the InFill Contour Oblique TLIF, the InFill ALIF, and the InFill Cervical Lordotic, and InFill Anatomic interbody devices.
Pinnacle also received CE Mark approval for its novel InFill Graft Delivery System, which initial studies have shown can place up to 94% more biologic between the vertebral bodies using the lateral approach than traditional prepacking of the implant
Zach Sowell, vice president of marketing for Pinnacle Spine, told OTW, “As for our plans for the European market, we are currently in discussions with a handful of distributors, and we will be in Lyon, France, for Eurospine. It is during this trip that we plan to hold a small meeting with our signed distributors to discuss plans for growing our footprint overseas.”
